The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy.
chronic pain
disability
function
opioids
Journal
Journal of pain research
ISSN: 1178-7090
Titre abrégé: J Pain Res
Pays: New Zealand
ID NLM: 101540514
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
03
2019
accepted:
23
05
2019
entrez:
30
7
2019
pubmed:
30
7
2019
medline:
30
7
2019
Statut:
epublish
Résumé
To examine the validity of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for the assessment of function in a community-based sample of patients with chronic pain conditions undergoing evaluation for chronic opioid therapy. One hundred nine of 124 patients were evaluated for a chronic opioid therapy program between December 1, 2014 and April 10, 2015, inclusive, at one community-based interdisciplinary pain management practice. Measures included: demographic data; the WHODAS 2.0; a modified version of the Roland Morris Disability Questionnaire (RMDQ-m); the Patient Health Questionnaire-9 item (PHQ-9); the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R); the Current Opioid Misuse Measure (COMM), the Opioid Risk Tool (ORT); opioid dose. These data were collected as part of routine care, and this retrospective chart review study examined the data from this convenience sample, comparing the results of each assessment tool to the results of the WHODAS 2.0. Median score on the WHODAS 2.0 was 25.69 (IQR=16.01 to 35.28). WHODAS 2.0 score was significantly correlated with the RMDQ-m (r The WHODAS 2.0 was significantly positively correlated with other measures, including measures of disability, risk of opioid misuse, and depression among patients being evaluated for chronic opioid therapy. The WHODAS 2.0 may be a useful measure of disability across a number of important domains when discussing expectations of both patients and providers at initiation of opioid therapy for chronic pain management. This assessment and discussion is crucial, particularly given the focus on function, rather than analgesia alone, when evaluating the effectiveness of opioid treatment.
Identifiants
pubmed: 31354334
doi: 10.2147/JPR.S207870
pii: 207870
pmc: PMC6573777
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1855-1862Déclaration de conflit d'intérêts
Dr Michael E Schatman is a consultant for Kaleo Pharma, outside the submitted work. The authors report no other conflicts of interest in this work.
Références
Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952
pubmed: 11074683
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3115-24
pubmed: 11124727
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Arthritis Rheum. 2001 Oct;45(5):453-61
pubmed: 11642645
Pain. 2004 Nov;112(1-2):65-75
pubmed: 15494186
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S100-8
pubmed: 16273793
Pain Med. 2005 Nov-Dec;6(6):432-42
pubmed: 16336480
Pain. 2007 Jul;130(1-2):144-56
pubmed: 17493754
J Pain. 2008 Apr;9(4):360-72
pubmed: 18203666
J Manipulative Physiol Ther. 1991 Sep;14(7):409-15
pubmed: 1834753
J Rheumatol. 2009 Jun;36(6):1304-11
pubmed: 19369473
J Addict Med. 2009 Jun;3(2):66-73
pubmed: 20161199
J Clin Epidemiol. 1991;44(6):561-70
pubmed: 2037861
Health Qual Life Outcomes. 2010 May 19;8:51
pubmed: 20482853
Clin J Pain. 2010 Nov-Dec;26(9):770-6
pubmed: 20842012
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
Disabil Rehabil. 2014;36(2):146-54
pubmed: 23586698
Pain. 2013 Jul;154(7):1038-44
pubmed: 23688575
Soc Psychiatry Psychiatr Epidemiol. 2015 May;50(5):797-806
pubmed: 25567235
Ann Intern Med. 2015 Feb 17;162(4):276-86
pubmed: 25581257
Pain. 2016 Jan;157(1):65-9
pubmed: 26307855
CMAJ Open. 2015 Jul 17;3(3):E324-30
pubmed: 26442231
N Engl J Med. 2015 Nov 26;373(22):2098-9
pubmed: 26605926
Pain. 2016 Apr;157(4):849-57
pubmed: 26785321
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
Spine (Phila Pa 1976). 2017 Jun 15;42(12):921-929
pubmed: 27792105
Disabil Rehabil. 2017 Nov;39(23):2347-2380
pubmed: 27820966
Pain Physician. 2017 Feb;20(2S):S3-S92
pubmed: 28226332
J Nerv Ment Dis. 2017 Oct;205(10):788-792
pubmed: 28763404
Headache. 2017 Oct;57(9):1385-1398
pubmed: 28857154
Pharmacoepidemiol Drug Saf. 2018 May;27(5):526-534
pubmed: 28879660
Pain. 2018 Mar;159(3):481-495
pubmed: 29194127
Eur Psychiatry. 2018 Mar;49:56-61
pubmed: 29366849
Pain Med. 2018 Feb 2;:null
pubmed: 29408996
J Pain. 2018 Jun;19(6):678-689
pubmed: 29496637
Spine (Phila Pa 1976). 1983 Mar;8(2):141-4
pubmed: 6222486